The nuclear PAK4-Erα-LIFR axis facilitates bone metastasis of ER+ breast cancers by initiating an EMT program, where high expression of nPAK4 is often associated with a poorer prognosis (118). This evidence concerns the gene LIFR and breast carcinoma.